Conference Material
|Video

24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial

Berry C, Motta I, Kazounis E, Fielding K, Dodd M, Nyang'wa BT, Moodliar R

Countries

Belarus South Africa Uzbekistan

Subject Area

antibiotic resistancetuberculosisantimicrobial resistance

Collections

TB-PRACTECAL Trial—Evidence for a shorter, safer, more effective treatment for drug-resistant tuberculosis

Languages

English
DOI
10.57740/atfr-ws57
Published Date
07 Jun 2022
Conference
MSF Scientific Days International 2022